Investments
39Portfolio Exits
2Funds
2About Oceanpine Capital
Oceanpine Capital is a professional investment management firm dedicated to long-term investment with a focus on value creation. The firm provides long-term capital and professional value-added services to high-growth enterprises and start-up companies, with a focus on investment opportunities in the TMT, consumption upgrade, advanced manufacturing, and healthcare sectors. It mainly invests in private companies with rapid growth, but also looks at some opportunities in public companies. Oceanpine Capital also operates Oceanpine Healthcare Fund (海松医疗基金), a healthcare venture fund that aims to connect innovation in the US to the Chinese consumer base and primarily invests in Chinese and US firms with core technologies and proprietary R&D capabilities.
Oceanpine Capital Headquarter Location
19F Tower H, Phoenix Place A5 ShuGuangXiLi, Chaoyang District
Beijing, Beijing, 100028,
China
+86 10 6195 9000
Latest Oceanpine Capital News
Aug 5, 2021
China Money Network’s DealShot provides detailed information on venture capital and private equity deals in China on a daily basis. Here you can find out where Chinese investors have been investing their money each workday. DealShot: 14 Deals Worth $95 Million With Eight Roads, Oceanpine Capital Among Others comes from China Money Network: Primary Data for China’s Primary Markets!…
Oceanpine Capital Investments
39 Investments
Oceanpine Capital has made 39 investments. Their latest investment was in MingMed Biotech as part of their Series A - II on September 9, 2021.
Oceanpine Capital Investments Activity
Date | Round | Company | Amount | New? | Co-Investors | Sources |
|---|---|---|---|---|---|---|
9/13/2021 | Series A - II | MingMed Biotech | $50M | Yes | 7 | |
8/4/2021 | Series B | Imperial Vision | $15.46M | Yes | 2 | |
7/30/2021 | Series B | SVOLT Energy | $1,580M | Yes | 10 | |
7/12/2021 | Series C | |||||
6/24/2021 | Seed VC - II |
Date | 9/13/2021 | 8/4/2021 | 7/30/2021 | 7/12/2021 | 6/24/2021 |
|---|---|---|---|---|---|
Round | Series A - II | Series B | Series B | Series C | Seed VC - II |
Company | MingMed Biotech | Imperial Vision | SVOLT Energy | ||
Amount | $50M | $15.46M | $1,580M | ||
New? | Yes | Yes | Yes | ||
Co-Investors | |||||
Sources | 7 | 2 | 10 |
Oceanpine Capital Portfolio Exits
2 Portfolio Exits
Oceanpine Capital has 2 portfolio exits. Their latest portfolio exit was Energy Monster on April 01, 2021.
Date | Exit | Companies | Valuation Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model. | Acquirer | Sources |
|---|---|---|---|---|---|
4/1/2021 | IPO | 2 | |||
Date | 4/1/2021 | |
|---|---|---|
Exit | IPO | |
Companies | ||
Valuation | ||
Acquirer | ||
Sources | 2 |
Oceanpine Capital Fund History
2 Fund Histories
Oceanpine Capital has 2 funds, including Oceanpine Capital Fund II.
Closing Date | Fund | Fund Type | Status | Amount | Sources |
|---|---|---|---|---|---|
12/30/2020 | Oceanpine Capital Fund II | $400M | 2 | ||
Nanjing Jiangbei Xinqu Medical Innovation Industry Fund |
Closing Date | 12/30/2020 | |
|---|---|---|
Fund | Oceanpine Capital Fund II | Nanjing Jiangbei Xinqu Medical Innovation Industry Fund |
Fund Type | ||
Status | ||
Amount | $400M | |
Sources | 2 |
Oceanpine Capital Team
3 Team Members
Oceanpine Capital has 3 team members, including current Chief Executive Officer, Dave Chenn.
Name | Work History | Title | Status |
|---|---|---|---|
Dave Chenn | Chief Executive Officer | Current | |
Liguang Chen | Founding Partner | Current | |
Jigang Sun | Founding Partner | Current |
Name | Dave Chenn | Liguang Chen | Jigang Sun |
|---|---|---|---|
Work History | |||
Title | Chief Executive Officer | Founding Partner | Founding Partner |
Status | Current | Current | Current |